In: Accounting
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:
1 |
Dec. 31, 20Y3 |
Dec. 31, 20Y2 |
|
2 |
Assets |
||
3 |
Cash |
$626,170.00 |
$585,760.00 |
4 |
Accounts receivable (net) |
227,840.00 |
208,880.00 |
5 |
Inventories |
641,390.00 |
616,790.00 |
6 |
Investments |
0.00 |
240,820.00 |
7 |
Land |
327,380.00 |
0.00 |
8 |
Equipment |
704,290.00 |
554,020.00 |
9 |
Accumulated depreciation-equipment |
(167,160.00) |
(148,930.00) |
10 |
Total assets |
$2,359,910.00 |
$2,057,340.00 |
11 |
Liabilities and Stockholders’ Equity |
||
12 |
Accounts payable (merchandise creditors) |
$424,670.00 |
$404,080.00 |
13 |
Accrued expenses payable (operating expenses) |
43,080.00 |
52,050.00 |
14 |
Dividends payable |
24,920.00 |
19,300.00 |
15 |
Common stock, $4 par |
140,000.00 |
102,000.00 |
16 |
Paid-in capital: Excess of issue price over par—common stock |
417,400.00 |
280,600.00 |
17 |
Retained earnings |
1,309,840.00 |
1,199,310.00 |
18 |
Total liabilities and stockholders’ equity |
$2,359,910.00 |
$2,057,340.00 |
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
A. | The investments were sold for $279,890 cash. |
B. | Equipment and land were acquired for cash. |
C. | There were no disposals of equipment during the year. |
D. | The common stock was issued for cash. |
E. | There was a $206,210 credit to Retained Earnings for net income. |
F. | There was a $95,680 debit to Retained Earnings for cash dividends declared. |
Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.
`````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````
Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.
Livers Inc. |
Statement of Cash Flows |
1 |
Cash flows from operating activities: |
||
2 |
|||
3 |
Adjustments to reconcile net income to net cash flow from operating activities: |
||
4 |
|||
5 |
|||
6 |
Changes in current operating assets and liabilities: |
||
7 |
|||
8 |
|||
9 |
|||
10 |
|||
11 |
|||
12 |
|||
13 |
Cash flows from investing activities: |
||
14 |
|||
15 |
|||
16 |
|||
17 |
|||
18 |
|||
19 |
Cash flows from financing activities: |
||
20 |
|||
21 |
|||
22 |
|||
23 |
|||
24 |
Cash at the beginning of the year |
||
25 |
Cash at the end of the year |
---------------------------------------------------------------------------------------------------------------------
Labels and Amount Descriptions | |
---|---|
Cash paid for dividends | |
Cash paid for merchandise | |
Cash paid for purchase of equipment | |
Cash paid for purchase of land | |
Cash received from customers | |
Cash received from sale of common stock | |
Cash received from sale of investments | |
Change in cash | |
December 31, 20Y3 | |
Decrease in accounts payable | |
Decrease in accounts receivable | |
Decrease in accrued expenses payable | |
Decrease in inventories | |
Depreciation | |
For the Year Ended December 31, 20Y3 | |
Gain on sale of investments | |
Increase in accounts payable | |
Increase in accounts receivable | |
Increase in accrued expenses payable | |
Increase in inventories | |
Loss on sale of investments | |
Net cash flow from operating activities | |
Net cash flow used for operating activities | |
Net cash flow from investing activities | |
Net cash flow used for investing activities | |
Net cash flow from financing activities | |
Net cash flow used for financing activities | |
Net income | |
Net loss |
Solution
Livers Inc
Statement of cash flows:
Livers Inc |
|||
Statement of Cash Flows (Indirect Method) |
|||
for the year ended December 31, 20Y3 |
|||
Cash flows from operating activities: |
|||
Net Income |
206,210 |
||
Adjustments to reconcile net income to net cash flow from operating activities: |
|||
Depreciation expense |
$18,230 |
||
gain on sale of investments |
($39,070) |
||
Changes in current operating assets and liabilities: |
|||
Increase in accounts receivable |
($18,960) |
||
Increase in inventory |
($24,600) |
||
increase in accounts payable |
$20,590 |
||
decrease in accrued expenses payable |
($8,970) |
||
increase in dividends payable |
$5,620 |
-$47,160 |
|
Cash flow from operating activities |
$159,050 |
||
Cash flow from investing activities: |
|||
Proceeds from sale of investment |
$279,890 |
||
Purchase of land |
($327,380) |
||
Purchase of equipment |
($150,270) |
||
Cash flow from investing activities |
($197,760) |
||
Cash flow from financing activities: |
|||
Issue of common stock |
$174,800 |
||
Dividends paid |
($95,680) |
||
Cash flow from financing activities |
$79,120 |
||
Excess of cash |
$40,410 |
||
Beginning balance |
$585,760 |
||
Ending cash balance |
$626,170 |
Note:
Cash from issue of common stock –
Increase in common stock par value = $38,000(140,000 – 102,000)
Add: increase in paid-in capital$136,800(417,400 – 280,600)
Cash from issue of common stock$174,800
Gain on sale of investments:
Sale proceeds$279,890
Less: Book value $240,820
Gain on sale $39,070
Depreciation expense and gain on sale of investments are non-cash items and hence added back to reconcile net income.